--- title: "GenScript Biotech climbs 6%" type: "News" locale: "en" url: "https://longbridge.com/en/news/305895347.md" description: "GenScript Biotech rose 6.21% to HK$31.46. Down 9.73% over five sessions and up 152.50% YTD." datetime: "2026-11-18T01:31:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/305895347.md) - [en](https://longbridge.com/en/news/305895347.md) - [zh-HK](https://longbridge.com/zh-HK/news/305895347.md) generator: "portal-rs" --- # GenScript Biotech climbs 6% GenScript Biotech (1548.HK) climbed more than **6%** in Hong Kong trading to **HK$31.46**. The stock is down 9.73% over the past five sessions and up 152.50% year to date. It sits 203.67% above its 52-week low of HK$10.36. The Hang Seng Index is down 3.92% over the past five sessions and down 8.85% year to date. The company has entered into a strategic partnership with Tencent Health on AI-driven drug discovery and development. The collaboration integrates Tencent's AI, high-performance computing and cloud capabilities with GenScript's life sciences experimental systems to advance a research model combining computational prediction with wet lab validation. GenScript will serve as a key wet lab validation partner for Tencent Health's BioNexus platform. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [01548.HK](https://longbridge.com/en/quote/01548.HK.md) ## Related News & Research - [M Stanley: China AI Drug R&D Financing Accelerates, GENSCRIPT BIO Benefits from Wet Lab Demand](https://longbridge.com/en/news/304828812.md) - [AIĆ¢s billions and slick pledges heap pressure on pharma veterans](https://longbridge.com/en/news/306270834.md) - [USD.AI: USD.AI unlocks at least 147.12 million CHIP - Sep 2027](https://longbridge.com/en/news/306378017.md) - [Huatai Raises GENSCRIPT B-1K Earnings Forecasts on AIDD Benefits, Reiterates Buy](https://longbridge.com/en/news/304381452.md) - [A Seattle Startup Brings Your Pet to Life on Your Phone and Laptop With the Avatar Mirroring Their Every Move in Real Time](https://longbridge.com/en/news/306379421.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**